Polyalkylimide is a polymer whose structure contains no free monomers. It is used in permanent dermal fillers to treat soft tissue deficits such as facial lipoatrophy,[1] gluteal atrophy, acne, and scars.[2]

In plastic and reconstructive surgery it is used for building facial volume in the cheeks, chin, jaw, and lips. Reports of infections[3] and migration of polyalkylimide in the face[4] has led Canada to remove it from the market, and the manufacturer of Biolcamid ceasing production. A class action lawsuit was filed against the company.

See also

edit

References

edit
  1. ^ Hönig, J. (2008). "Cheek Augmentation with Bio-Alcamid in Facial Lipoatrophy in HIV Seropositive Patients" (PDF). Journal of Craniofacial Surgery. 19 (4): 1085–1088. doi:10.1097/SCS.0b013e31811eda9c. PMID 18650737. S2CID 608532. Archived from the original (PDF) on 2019-03-03.
  2. ^ Pacini, S.; Ruggiero, M.; Morucci, G.; Cammarota, N.; Protopapa, C.; Gulisano, M. (2002). "Bio-alcamid: A novelty for reconstructive and cosmetic surgery". Italian Journal of Anatomy and Embryology. 107 (3): 209–214. PMID 12437147.
  3. ^ Canada, Health (16 December 2010). "ARCHIVED - Canadian Adverse Reaction Newsletter, Volume 21 - Issue 1 - January 2011". aem.
  4. ^ "Complications reported in some recipients of Bio Alcamid". www.catie.ca.